Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 72.8% in February

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a large decrease in short interest in the month of February. As of February 13th, there was short interest totaling 99,130 shares, a decrease of 72.8% from the January 29th total of 364,031 shares. Based on an average daily volume of 129,496 shares, the short-interest ratio is currently 0.8 days. Approximately 2.3% of the shares of the company are short sold. Approximately 2.3% of the shares of the company are short sold. Based on an average daily volume of 129,496 shares, the short-interest ratio is currently 0.8 days.

Ainos Stock Performance

Ainos stock opened at $1.64 on Thursday. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.96 and a quick ratio of 2.67. The stock has a fifty day moving average price of $1.82 and a two-hundred day moving average price of $2.71. Ainos has a 52-week low of $1.26 and a 52-week high of $4.50. The firm has a market capitalization of $7.89 million, a P/E ratio of -0.41 and a beta of 2.50.

Insider Transactions at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the business’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total transaction of $99,820.00. Following the transaction, the insider owned 989,925 shares in the company, valued at approximately $2,148,137.25. The trade was a 4.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders have sold 47,281 shares of company stock valued at $102,152. Company insiders own 9.79% of the company’s stock.

Hedge Funds Weigh In On Ainos

Institutional investors have recently added to or reduced their stakes in the company. Mariner LLC bought a new stake in Ainos during the fourth quarter worth about $37,000. Two Sigma Investments LP acquired a new position in shares of Ainos in the 3rd quarter worth approximately $80,000. DRW Securities LLC grew its position in Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after acquiring an additional 48,439 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after purchasing an additional 7,700 shares in the last quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Ainos in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.